PK11007 is a thiol-reactive anticancer agent that stabilizes p53 through selective alkylation of two surface cysteines without compromising its DNA binding. It induces mutated p53 cancer cells to die by increasing levels of reactive oxygen species (ROS).

 

Brand: BCM

 

Target: Reactive Oxygen Species; p53

 

Signaling Pathways: Apoptosis; Immunology/Inflammation; Metabolism; NF-κB

 

In Vivo: Targeting mutant p53 with PK11007 is a potential approach for treating p53-mutated breast cancer, including the subgroup with TN disease.

 

pKa: 4.18±0.50(Predicted)

 

Solubility: Soluble in DMSO. Soluble in Water; Soluble in Ethanol.

 

GHS: GHS07

 

Isomeric SMILES: CC1=NN=C(S1)NC(=O)C2=NC(=NC=C2Cl)S(=O)(=O)CC3=CC=C(C=C3)F  

 

InChIKey: IVZQUWCWXYFPOQ-UHFFFAOYSA-N  

 

InChI: InChI=1S/C15H11ClFN5O3S2/c1-8-21-22-14(26-8)20-13(23)12-11(16)6-18-15(19-12)27(24,25)7-9-2-4-10(17)5-3-9/h2-6H,7H2,1H3,(H,20,22,23)

 

Attribute
[Chem Name]	5-chloro-2-[(4-fluorophenyl)methylsulfonyl]-N-(5-methyl-1,3,4-thiadiazol-2-yl)pyrimidine-4-carboxamide
[Synonym]	PK11007
[CAS No.]	874146-69-7
[MDL No.]	MFCD07427349
[Formula]	C15H11ClFN5O3S2
[Molecular]	427.86
[Form]	Solid Powder
[Storage]	Sealed in dry, 2-8°C

Goods Tag